Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Wrong

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Oct 21, 2021 11:21am

80 Views

Post# 34032711

RE:Wrong

Its like a letter for Guy to attend playschool, but he will be in a special class, you pumpers are jumping up and down like he is going to graduate in 30 days.All this does is label the drug and that will be done in 30 days . Once again years away from anything , you read it again if you can.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"